Objective: Two methods of subatmospheric pressure wound therapyVwall suction applied to a sealed gauze dressing (GSUC) and the vacuum-assisted closure device (VAC)Vwere compared in hospitalized patients at University of Chicago Medical Center. Summary of Background Data: VAC therapy is widely used, but can be expensive and difficult to apply; it also fails in some patients. Methods: A randomized prospective study of 87 patients (N = 45 in the GSUC arm and N = 42 in the VAC arm) was undertaken between October 2006 and May 2008. The study comprised patients with acute wounds resulting from trauma, dehiscence, or surgery. Results: Demographics and wound characteristics were similar in both groups. There were significant reductions in wound surface area and volume in each group. In the GSUC group, the reductions in wound surface area and volume were 4.5%/day and 8.4%/day, respectively (P G 0.001 for both), and in the VAC group, this was 4.9%/day and 9.8%/day, respectively (P G 0.001 for both). The reductions in wound surface area and volume were similar in both groups (P = 0.60 and 0.19, respectively, for the group-by-time interaction). The estimated difference (VAC j GSUC) was 0.4% (95% confidence interval: j1.0, 1.7) for wound surface area and 1.4% (95% confidence interval: j0.7, 3.5) for volume. The mean cost per day for GSUC therapy was $4.22 versus $96.51 for VAC therapy (P G 0.01) and the average time required for a GSUC dressing change was 19 minutes versus 31 minutes for a VAC dressing change (P G 0.01). The sum of pain intensity differences was 0.50 in the GSUC group compared with 1.73 for the VAC group (P = 0.02). Conclusions: GSUC is noninferior to VAC with respect to changes in wound volume and surface area in an acute care setting. In addition, GSUC dressings were easier to apply, less expensive, and less painful.
S ubatmospheric pressure wound therapy (SAWT) was initially described in the 1980s and 1990s 1Y8 ; it was introduced in the United States in 1997 9, 10 and has rapidly become the standard of care in many situations. 9, 10 Our unit primarily used the vacuumassisted closure device (VAC; Kinetics Concepts, Inc., San Antonio, TX) for SAWT but some drawbacks were noted. 11, 12 For example, VAC can be difficult to apply and is expensive. It can also be painful, and is controversial for infected wounds. We began to explore an alternative method of SAWT using sealed gauze dressing and wall suction, which we called GSUC. GSUC is similar to the methods used in earlier descriptions of SAWT. 13Y16 Before this study, clinical trials have not evaluated different modalities of SAWT. 17Y20 Here, the commercial VAC and the off-the-shelf GSUC are directly compared in a prospective randomized trial involving patients hospitalized with acute wounds. The primary outcomes studied were the percent change in wound surface area and volume. To our knowledge, this is the first time that detailed quantification of the rate of change in wound surface area and volume has been achieved using SAWT methods in human subjects.
METHODS
A prospective, randomized trial was designed according to CONSORT guidelines, 21, 22 approved by the University of Chicago Medical Center Institutional Review Board, and registered at www.clinicaltrials.gov; the Clinical Trials Identifier Number is NCT00724750.
Participants
Patients admitted to University of Chicago Medical Center, 918 years of age, with acute wounds resulting from trauma, dehiscence, or surgery, between October 2006 and May 2008, were eligible for the study. Table 1 illustrates exclusion criteria. All patients who were eligible were offered the opportunity to participate in the study.
Interventions
In the VAC arm, GranuFoam black sponge (KCI, San Antonio, TX) was applied to the wounds and sealed with an occlusive plastic cover; continuous suction at 75 to 125 mm Hg was initiated and the dressing was changed every 48 hours, as recommended by VAC therapy guidelines. All components of the dressing were obtained from Kinetics Concepts, Inc. In the GSUC arm, a gauze dressing (Kerlix 4.5 inch roll, Covidien, Mansfield MA) moistened with 0.9% normal saline was applied to the wounds, a red rubber catheter (C.R. Bard, Covington, GA) was placed in the center of the dressing, and the dressing was then sealed with an occlusive cover (Ioban Antimicrobial Incise Drape, 3M, St Paul, MN). Continuous wall suction at 75 to 80 mm Hg was applied and the dressings were changed daily, as recommended for optimal healing in the original descriptions of this technique. 1Y5
Failure of Intervention
Failure of SAWT occurred in either of 2 situations: (1) A dressing could not be maintained because of persistent fluid or suction leaks. If, after 2 attempts in a 24-hour period to reinforce the dressing, the seal could not be maintained, that patient was considered to have failed SAWT. Patients who failed one method of SAWT could cross over to the other treatment arm. (2) If a patient developed an invasive or progressive wound infection, or systemic sepsis resulting from a wound infection, SAWT was discontinued. These patients were then managed by debridement and by topical and intravenous antibiotics.
Objectives
The primary objective was to compare the efficacy of VAC and GSUC with respect to changes in wound size. Secondary objectives were to compare associated costs of the dressings, the ease of application, and the pain associated with each dressing change. We hypothesized that GSUC would not be inferior to VAC with respect to changes in wound size, but that GSUC might be less expensive, potentially easier to apply, and less painful than VAC.
Outcomes
The primary outcomes used to assess efficacy were change in wound surface area and volume over time. The dimensions of each wound were documented at each dressing change. Wound size was calculated using the Xakellis and Frantz method: wound surface area = length Â width Â 0.783; wound volume = area Â depth Â 0.327. 23 The percent changes, from baseline, in wound volume and surface area were calculated over the course of the patient's hospital stay.
Direct costs for each type of dressing were also measured. In the VAC group, this included rental charges for the equipment and the cost of supplies. In the GSUC group, this included the cost of supplies (suction canisters, catheters or drains, tubing, gauze, and adhesive drapes). Direct labor costs for each dressing change were also documented.
The ease of dressing application was assessed by the time required to change each dressing. Time was measured from the start of the dressing change until the initiation of suction.
Self-reported pain levels, and the amount of analgesic required for each dressing change were used to assess pain. Patients were asked to rate their pain level according to the 0 to 10 linear analog scale immediately before, during, and after removal of the dressing. The sum of pain intensity differences (SPID) was used to facilitate comparison of pain levels between the 2 groups. The SPID score was calculated using the formula: (pain during j pain before) + (pain after j pain during). 24 Patients had ad lib access to analgesics administered via PCA or a nurse. The total amount of analgesic medication (as measured by morphine equivalents) administered with each dressing change was recorded.
Sample Size
The sample size was calculated to allow comparison of changes in wound surface area and volume. Since we expected GSUC and VAC to have a similar effect on wound size, a noninferiority testing strategy was used. The noninferiority margin chosen was 5%/day, that is, the data would support noninferiority of GSUC if the reduction in wound volume or surface area was no more than 5%/ day greater with VAC compared with GSUC. For 80% statistical power and a significance (alpha) level of 0.05; and assuming a common standard deviation of 5% or 9%, 14 or 41 subjects per group were needed, respectively. The larger number of subjects was used to allow for greater variability in the data. Additional subjects were enrolled to allow for dropout.
Randomization
On enrollment, patients were then randomized to either GSUC or VAC therapy in a 1:1 ratio by drawing a previously prepared card. The randomization sequence was generated from the Web site http://www.randomization.com.
Blinding
The 2 methods of SAWT were obviously and visibly different, so it was impossible to blind either the therapists or the patients to the method of treatment.
Statistical Methods
Demographics, wound characteristics, and secondary outcomes were compared between groups using W 2 or Fisher exact tests for categorical variables and 2-sample t test or nonparametric Wilcoxon rank-sum test for continuous variables. The percent change over time of wound volume and surface area from baseline was compared between groups using a linear mixed model. The rate of change for the 2 groups was compared by testing the treatment-by-time interaction (ie, the treatment effect) in the model and constructing the 95% confidence interval (CI). If the 95% CI did not contain the noninferiority margin (5%/day), then GSUC would be deemed noninferior to VAC. SPID scores are reported as least square means, and analgesic requirements are reported as the morphine equivalent dose. The linear mixed model was used to allow for simultaneous analysis of multiple wounds per patient and the multiple time points each wound was measured. Data were analyzed using STATA software (Stata Corp., College Station, TX).
RESULTS

Participant Flow
Refer to Figure 1 for participant flow diagram.
Recruitment
During the study 246 patients were treated with SAWT, and all were assessed for eligibility. Of these patients, 94 who did not meet eligibility criteria and 43 who were unable to consent because of sedation, diminished mental capacity, or endotracheal intubation, etc, were excluded. There were 22 who were eligible but declined to participate. A total of 87 patients enrolled in the study and 45 were assigned to the GSUC group and 42 to the VAC group. All patients completed the study. There were no deviations from, or modifications of the protocol, and all patients were included in the analysis.
Patient Details
The clinical characteristics of each group were similar, except that patients in the GSUC arm underwent a mean of 4.5 (range, 2Y15) dressing changes versus 2.8 (range, 2Y6) in the VAC arm (P G 0.01). This was concordant with our study design ( Table 2 ). The anatomic distribution and etiology of the wounds, general medical condition, and demographic factors were similar in both groups (Fig. 2 ).
Numbers Analyzed
An intention-to-treat analysis was performed for all of the primary and secondary outcomes. Forty-five patients in the GSUC group and 42 patients in the VAC group were included in the analyses. Patients were studied between 4 and 18 days. However after 7 days, most of the patients were either discharged or underwent operative closure of their wounds. This left too few observation points after day 7 for meaningful statistical treatment of that portion of the data. The analysis presented here includes only data collected during the first 7 days of the trial.
Primary Outcomes
There were 106 wounds studied (56 in the GSUC group and 50 in the VAC group). The GSUC group consisted of 37 patients with 1 wound, 5 patients with 2 wounds, and 3 patients with 3 wounds. The VAC group consisted of 36 patients with 1 wound, 4 patients with 2 wounds, and 2 patients with 3 wounds. All wounds in all patients were included in the analysis.
There was a reduction in wound surface area in both groups. The rate of change was 4.5%/day for GSUC and 4.9%/day for VAC (P G 0.001 for both). However, the rate of change between the groups was not significantly different (P = 0.60 for the group-by-time interaction), with the estimated difference (VAC j GSUC) being 0.4%, 95% CI (j1.0, 1.7) ( Fig. 3 ; Table 3 ). There was also a reduction in wound volume in both groups: 8.4%/day for GSUC and 9.8%/day for the VAC group (P G 0.001 for both). The rate of change was not significantly different between the groups (P = 0.19 for the groupby-time interaction). The estimated VAC j GSUC difference was 1.4%, 95% CI (j0.7, 3.5) ( Fig. 4 ; Table 3 ). For both wound surface Fisher exact test demonstrated no statistically significant difference between groups (P = 0.59).
area and volume, the 95% CIs did not contain the prespecified noninferiority margin of 5%/day, that is, GSUC was not inferior to VAC.
Secondary Outcomes
The mean cost of supplies equipment for VAC therapy was $96.51/day and this was more than the costs of GSUC therapy at $4.22/day (P G 0.01) ( Table 4 ). The average cost of labor for a therapist was $40.70 to change a VAC dressing and $25.16 for a GSUC dressing. However, given that the GSUC dressings were changed more often, direct cost of labor over time was similar for both groups ($21.18/day for GSUC vs. $25.55/day for VAC, P = 0.11). The mean time required to change a GSUC dressing was 19 minutes vs. 31 minutes for a VAC (P G 0.01) ( Table 4 ).
There were 438 SIPD observations. Patients in the GSUC arm reported less overall pain (SPID = 0.50, 95% CI: j0.11Y1.11) than did patients in the VAC arm (SPID = 1.73, 95% CI: 0.91Y2.54), P = 0.02 (Table 4 ). There was no association between the dose of morphine equivalent used and dressing type, P = 0.63.
Failure of Intervention
No patients discontinued GSUC therapy. However, VAC therapy was discontinued in the following 4 patients. (1) A patient with an infected perineal wound where the VAC seal could not be maintained after 4 days; this patient successfully crossed over to GSUC. (2) A patient with an infected abdominal and flank wound after evacuation of a retroperitoneal hematoma, the VAC seal could not be maintained because of excessive fluid drainage. This patient also successfully crossed over to GSUC therapy after 4 days. (3) A patient with an upper extremity wound after fasciotomy, the VAC seal could not be maintained because of the patient's excessive movement; this patient was also crossed over to GSUC therapy at day 5. (4) A patient with a lower extremity wound following fasciotomy, VAC therapy was discontinued when a hematoma developed under the dressing after 5 days. This patient did not transition to GSUC therapy. Data collected after patients crossed over to the other arm was not included in the analysis of the results.
Adverse Events
As noted above, 1 patient in the VAC group developed a hematoma. This patient with thromboembolic disease was fully anticoagulated with heparin and the VAC was used for lower extremity wounds following compartment release. No patients had unexpected reactions to the dressings, and no patients prematurely left the study.
DISCUSSION
Background
The VAC is widely used, and most clinicians believe it is effective. 9,10 Nevertheless, the indications and expected benefits of VAC therapy are not clearly identified. The majority of articles about the VAC are retrospective case series or laboratory studies. Very limited level 1 data compares VAC therapy to other methods of wound management. Moreover, while other authors describe alternative methods of SAWT, 13Y16 they have not previously compared different methods of SAWT. 17Y20
Key Findings
We directly compared VAC and GSUC dressings in a prospective randomized trial for acute, inpatient wounds. A noninferiority design was used since we expected similar treatment effects in both groups, and we were willing to accept a somewhat smaller reduction with GSUC compared with VAC due to the other expected benefits of GSUC. To the best of our knowledge, this is the first study involving human beings to quantify the rate of change in wound size in response to SAWT. The treatment effect on wound surface area and volume was similar for the 2 SAWT methods and GSUC was noninferior to VAC for this outcome.
In our experience, VAC therapy is associated with 2 main problems. First, it is difficult to apply and maintain in some circumstances. This is particularly true for wounds with excessive drainage, for example, those adjacent to stomas, orifices, or cavities; for wounds near orthopedic hardware or other devices; and in situations where there is excessive movement. In this series, 4 patients, approximately 10%, had to discontinue VAC therapy. For 3 patients, the seal could not be maintained because of movement or wound drainage. We have found GSUC to be more reliable because the seal is easier to maintain in these circumstances and it was not necessary to discontinue GSUC therapy for any patient for similar reasons. Furthermore, 1 patient developed a hematoma under a VAC dressing. Neither the device alarm, nor the fact that a smaller canister was used drew attention to this event. Some authors have raised concerns over the potential for dangerous bleeding when patients are attached to a vacuum pump with a large reservoir and no safety alarm 25 as is the case with GSUC. There is little reported evidence to support this concern, and there were no episodes of bleeding under GSUC dressings in this trial; nor have there been episodes of clinically significant bleeding in more than 500 other patients we have treated with GSUC (Franczyk, personal communication, 2008). 26 However, it is likely that bleeding can occur under any type of SAWT dressing, and that no device will prevent bleeding if a patient is predisposed to it.
The second problem is that VAC dressings are painful. 27 We observed anecdotally that the GSUC dressings seemed to cause less pain than VAC. The SPID technique is useful for analyzing the response of multiple patients to a stimulus repeated over time. In this study, SPID scores were lower for patients treated with GSUC dressings compared with VAC dressings.
Cost-Effectiveness and Ease of Application
The cost of equipment and supplies for GSUC is much less than for VAC, and equipment rental is the greatest expense associated with VAC use. Additionally, VAC supplies are sometimes difficult to obtain, whereas GSUC supplies are almost always available. In fact, we initially began to use GSUC because VAC supplies were periodically unavailable. Beyond equipment issues, GSUC dressings can be applied more rapidly, potentially reducing the cost of labor. We looked for a quantitative variable that would reflect ease of application and choose to measure the time required for each dressing change. There are several reasons why GSUC dressings can be changed more rapidly than VAC dressings. For one, less tissue grows into the gauze dressings compared with the foam dressings. 28 Removal of gauze dressings is more comfortable and therefore patients are less likely to interrupt the therapist during removal of the dressing. Furthermore, gauze dressings are easier to apply than foam dressings. Gauze is more compliant, and readily conforms to the shape of the wound without trimming and shaping as is required with foam. However, the potential cost benefit associated with more rapid dressing changes was offset by our study protocol, which called for more frequent GSUC dressing changes.
Mechanisms
SAWT can be considered a ''black box'' system. The system is made up of several components, including at least suction, foam or gauze, the wound, and the patient. These components interact with one another in a complex way that is not fully understood to produce a treatment effect. Using more of a reductionist approach in the laboratory, other authors have studied the specific effect of foam and found that microdeformation of cells which occurs when suction is applied to foam induces signal transduction, cell division, and increased blood flow. 29 Furthermore, open-cell foam may facilitate removal of wound exudates. 30 They concluded that the combination of polyurethane foam (400Y600 Km) and 125 mm Hg of suction is important for wound healing. 9, 31 Similar data about the effect of gauze are not available. However, this trial raises the possibility that the clinical effect of a gauze system for SAWT is similar to that of a foam system. It may be that the particular type of dressing between the wound and the source of suction is not as important as the presence of one in inducing the treatment effect. Alternatively, it may be possible that gauze and foam perform better in different types of wounds. Larger, stratified trials would be required to answer this question.
Limitations
This study has 4 limitations. It was not blinded which raises the potential for investigator bias. A senior therapist who was highly experienced with both VAC and GSUC changed all of the dressings. We tried to minimize bias by using therapists who were not participating in the study to gather and record data. Second, we did not think it was possible or useful to control every aspect of the different techniques of SAWT used in the study. This allowed us to compare the best practice, and most commonly used system of gauzed-based SAWT with the best practice, and most commonly used system of VAC at the time of the study design. The VAC dressings were changed 3 times a week with pressure settings of 75 to 125 mm Hg. Although clinical data on human beings are scarce, the VAC dressing is expected to perform in a similar manner across this range of settings. 9 According to the best clinical practice at the time, GSUC dressings were changed daily with pressure settings of 75 to 80 mm Hg. We did not have experience with gauze dressings left in place for longer periods, and our IRB was unwilling to allow us to deviate from what was considered to be the best clinical practice. Currently, we change GSUC dressings 3 times a week but still use 75 to 85 mm Hg suction. Third, although the study was sufficiently powered, the sample size is relatively small and the study was conducted at a single institution. Finally, we were experienced with the GSUC before the study, and thus our results may not generalize to less experienced groups. There is a learning curve associated with GSUC, but the dressing is simple to use and expertise is acquired rapidly.
CONCLUSIONS
Negative pressure wound therapy can be considered to be a commodity when used in the manner described above. For acute wounds, in an inpatient setting, the type of dressing (gauze or foam) and the source of suction do not influence the clinical outcome with respect to changes in wound size and volume. Gauze dressings have potential benefits with respect to reduced cost, reduced pain, and more expedient application compared with foam dressings. In light of our cumulative findings, we have abandoned VAC therapy and now use GSUC exclusively in our hospital. Nevertheless, only larger, multiinstitutional, randomized trials will provide definitive evidence about the efficacy of different systems for negative pressure wound therapy. Likewise, studies that use time to wound closure as an end point, and also include outpatients, would also be informative.
